42nd Annual Telluride Mushroom Festival

Many studies with psilocybin focus on a one-on-one session setting, but what about the concept and benefits of group sessions? Irene Dubin, lead psychotherapist and facilitator of the Blue Portal, compares and discusses how each strategy functions and benefits the participants, the importance of harm reduction in psychedelic treatments and integration principles of mystical experiences through the lens of Carl Jung psychoanalysis. Come and experience how peer-reviewed clinical research with PTSD, OCD, anxiety and depression can benefit participants in group settings and shape the future of psychedelic treatment strategies.